ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

NCI Awards 41.5 Million for DES Study

February 28, 1975

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013